Patients
4.1 per 100,000 people
Suicide rate, Malaysia, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Vidhi Upadhyay
Malaysia Bipolar Disorder Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $9.8 Mn | — | — |
| 2025 (base) | $10.3 Mn | +$0.5 Mn | — |
| 2026 (forecast) | $10.8 Mn | +$0.5 Mn | +4.6% |
| 2027 (forecast) | $11.3 Mn | +$0.5 Mn | +9.4% |
| 2028 (forecast) | $11.8 Mn | +$0.5 Mn | +14.4% |
| 2029 (forecast) | $12.3 Mn | +$0.5 Mn | +19.7% |
| 2030 (forecast) | $12.9 Mn | +$0.6 Mn | +25.2% |
| 2031 (forecast) | $13.5 Mn | +$0.6 Mn | +31% |
| 2032 (forecast) | $14.1 Mn | +$0.6 Mn | +37% |
| 2033 (forecast) | $14.7 Mn | +$0.6 Mn | +43.3% |
| 2034 (forecast) | $15.4 Mn | +$0.7 Mn | +49.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $10.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $15.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 4.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Drug class, type and end user (see all) |
| Key players | AbbVie Inc., Otsuka Pharmaceutical Co., Ltd., Intra-Cellular Therapies, Sumitomo Pharma, GSK PLC (see all) |
| Regulator in Malaysia | NPRASource: National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Bipolar disorder treatment uses mood stabilisers, antipsychotics and therapy to control manic and depressive episodes.
Key segments of the bipolar Disorder Treatment market include drug class (Mood Stabilizers, Antipsychotics and Antidepressants) and type (Bipolar I, Bipolar II and Cyclothymia).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the bipolar Disorder Treatment market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the bipolar Disorder Treatment market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the bipolar Disorder Treatment market.
The bipolar Disorder Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines must be registered with the Drug Control Authority, which works through the National Pharmaceutical Regulatory Agency (NPRA).[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.[2] Suicide rate: 4.1 per 100,000 people in 2023, the latest WHO figure for Malaysia.[3]
[1] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
[2] Ministry of Health Malaysia. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 15 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for bipolar Disorder Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Malaysia.
What doctors and scientists are doing in Bipolar Disorder Treatment right now, from free public sources.
4.1 per 100,000 people
Suicide rate, Malaysia, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
Malaysia · 2 shared keywords
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia
Malaysia
OTC & Nutraceuticals · Malaysia
Digital Health · Malaysia
Digital Health · Malaysia
OTC & Nutraceuticals · Malaysia
Healthcare Services · Malaysia
Healthcare Services · Malaysia